Biotronik Executive and Leadership Team

James Felsted, the Vice President, Finance & Chief Financial Officer, Administration, Region (US) at Biotronik, directs financial strategy and administration for the US region. Overseeing fiscal operations, Felsted ensures robust financial planning, accurate reporting, and effective resource allocation to support Biotronik's growth objectives in the medical technology sector. This leadership role involves managing budgets, optimizing financial performance, and maintaining compliance with regulatory standards. By driving financial discipline, James Felsted directly contributes to the company's operational efficiency and long-term economic stability. The scope of this position includes managing all financial aspects critical to the company's success in the United States market, aligning fiscal policies with overarching corporate goals.

Ryan Walters, the President at Biotronik, directs overall business strategy and operational execution. Walters spearheads initiatives to expand market reach and enhance Biotronik's comprehensive solutions in cardiac rhythm management, electrophysiology, and vascular intervention. This executive position involves fostering cross-functional collaboration to drive innovation and ensure seamless delivery of diagnostic, treatment, and therapy support services. By setting strategic priorities and overseeing key business units, Ryan Walters champions the company's mission to improve patient outcomes globally. The President's leadership is fundamental to maintaining Biotronik's competitive edge and achieving sustained growth in the dynamic medical device industry.

Todd Langevin, the President Neuromodulation at Biotronik, leads the strategic development and commercialization of neuromodulation technologies. Langevin drives innovation within this specialized sector, focusing on advanced solutions for neurological conditions. This leadership role encompasses overseeing research, product development, and market expansion for Biotronik's neuromodulation portfolio. By fostering a culture of scientific excellence and market responsiveness, Todd Langevin ensures that Biotronik remains at the forefront of therapeutic advancements. The President Neuromodulation's efforts are critical to delivering cutting-edge treatments that address unmet patient needs and enhance quality of life.

Roberto Alvarenga, the Vice - President -LA at Biotronik, manages and expands Biotronik's operations and market presence across Latin America. Alvarenga directs regional sales, distribution, and customer support strategies to ensure the effective delivery of the company's comprehensive solutions in cardiac rhythm management, electrophysiology, and vascular intervention. This executive role involves building strong relationships with healthcare providers and stakeholders throughout the region. By driving regional growth initiatives, Roberto Alvarenga plays a key part in extending Biotronik's impact and improving patient care across Latin America. The Vice - President -LA's focus is on achieving ambitious business objectives and solidifying Biotronik's leadership position in this vital market.

David Hayes, the Chief Medical Officer at Biotronik, provides critical medical and scientific leadership. Hayes guides the company's clinical strategy, ensuring that product development and therapeutic solutions align with the highest medical standards and patient needs. This role involves close collaboration with research and development teams, as well as external medical communities, to advance the understanding and application of Biotronik's technologies in cardiac rhythm management, electrophysiology, and vascular intervention. By translating clinical insights into actionable strategies, David Hayes enhances the efficacy and safety of the company's offerings. The Chief Medical Officer's expertise is vital for maintaining Biotronik's reputation for innovation and patient-centric care.